New EU Rybrevant Approval Decisions Turn The Screw On Tagrisso

 
• By Alexandra Shimmings

A manufacturing inspection issue may have put paid to J&J getting a rapid approval for its subcutaneous version of Rybrevant in the US, but a positive opinion from the CHMP plus an expanded EU approval for the IV version are two recent boosts to a franchise taking aim at Tagrisso’s crown.

Holographic concept of lung cancer display, lung disease, treatment of lung cancer, lung illness
• Source: Shutterstock

More from New Products

More from Therapy Areas